Free course trains agents against illegal supplies
Registration for the training program offered by USP and CropLife Brasil is now open
The bioinputs sector in Brazil continues to expand and could reach a turnover of over R$9 billion by the end of the decade. The data was presented this Tuesday (25/2) by the National Association for the Promotion and Innovation of the Biological Industry (ANPII Bio) during the 2nd ANPII Bio Market Intelligence Workshop.
The survey indicates that the sector moved R$5,7 billion in the last harvest, covering an area of 156 million hectares.
The projection is for a 60% growth by 2030, driven by the increasing adoption of technologies such as nutrient solubilizing inoculants and bioinsecticides. The estimate is that industries in the sector will advance 12,4% per year in the sale of inoculants and 20,4% in the biodefensives market.
Data collected from 23 companies associated with ANPII Bio reveal a growth of 4,9% and 12,6% in sales value and an increase of 12,4% and 29,1% in the volume of inoculants and biodefensives sold, respectively.
Although growth is below that recorded in previous years, the sector remains confident.
The beginning of 2025 still presents challenges such as a reduction in purchases, lower profitability for grain producers and credit restrictions.
"The sector remains optimistic, despite the uncertain scenario. The adoption of bioinputs continues to grow, consolidating its relevance", says Anderson Nora Ribeiro, founding partner of 5P2R Marketing de Precisão.
With an 11,3% share of the global bioinputs market, Brazil stands out as one of the main consumers of these products. In segments such as bioinoculants and biodefensives, this rate rises to 12,6%, with a forecast of reaching 16,4% by 2030. This means that one sixth of global consumption will come from Brazilian agriculture by the end of the decade.
The recent approval of the Bioinputs Law, sanctioned in 2024, should further boost this growth by establishing a regulatory framework for the production and commercialization of biological inputs in the country.
"The new legislation should reduce bureaucracy and create incentives for research and development of multifunctional products," explains Larissa Simon, operations director at ANPII Bio.
The 2nd ANPII Bio Market Intelligence Workshop took place on February 24th and 25th, in Campinas (SP), bringing together around 120 participants, including business leaders and industry experts. Among the topics covered: impact of the new legislation, agricultural financing in the context of the 2024/25 Harvest Plan and trends for the biodefensives market.
Receive the latest agriculture news by email